LifeScience
Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria
Biotium, a leading innovator of fluorescent dyes for life science research, proudly announces the launch of its breakthrough ...
October 26, 2023 | News
Lonza's Rapid PyroCell® Enhances Rabbit-Free Pyrogen Testing
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems...
October 25, 2023 | News
CBC Healthcare Infrastructure Platform Secures US$875 Million with Mubadala Investment
Following the initial close in November 2021 and the successful closing of four projects, CBC HIP continues to generate substantial pipeline, and t...
October 23, 2023 | News
Waters Launches OligoWorks™ SPE Workflow and Kits for Faster Oligonucleotide Bioanalysis
Delivers up to 2x[i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitati...
October 23, 2023 | News
SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
Thermo Fisher Scientific Acquires Next-Gen Proteomics Leader Olink
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing...
October 18, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
Discovery Life Sciences Reveals Major Expansions: New Facilities, Tech, and Global Brand Upgrades
With support from the State of Alabama and HudsonAlpha, Discovery has opened its new 93,000-square-foot global headquarters building in ...
October 13, 2023 | News
MediLink and BioNTech Partner for Advanced Anti-Cancer Drug
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...
October 13, 2023 | News
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...
October 10, 2023 | News
Agilent & Sarawak Infectious Disease Centre to Enhance Tropical Disease Research in East Malaysia
Neglected tropical diseases (NTDs) are a diverse group of 20 conditions that are mainly prevalent in tropical areas, where they primarily affect impov...
October 09, 2023 | News
Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers
Merck, a leading science and technology company, announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to pr...
October 06, 2023 | News
Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024
This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...
October 04, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
